Rats that are made insulin resistant by glucosamine treatment have impaired skeletal muscle insulin receptor phosphorylation. (Q44594404)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14506612%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Rats that are made insulin resistant by glucosamine treatment have impaired skeletal muscle insulin receptor phosphorylation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14506612%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

1 reference

1 reference

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14506612%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Riccardo Vigneri

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14506612%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

9

L Frittitta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14506612%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

author name string

D Spampinato

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14506612%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

A Giaccari

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14506612%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

B V Costanzo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14506612%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

L Morviducci

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14506612%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

A Buongiorno

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14506612%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

U Di Mario

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14506612%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

publication date

1 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14506612%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14506612%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14506612%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14506612%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

1092-1095

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14506612%20AND%20SRC:MED&resulttype=core&format=json

In vivo effects of glucosamine on insulin secretion and insulin sensitivity in the rat: possible relevance to the maladaptive responses to chronic hyperglycaemia

19 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900182-3

Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900182-3

Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900182-3

Discordant effects of glucosamine on insulin-stimulated glucose metabolism and phosphatidylinositol 3-kinase activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900182-3

Glucosamine-induced insulin resistance in 3T3-L1 adipocytes is caused by depletion of intracellular ATP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900182-3

PC-1 content in skeletal muscle of non-obese, non-diabetic subjects: relationship to insulin receptor tyrosine kinase and whole body insulin sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900182-3

Elevated PC-1 content in cultured skin fibroblasts correlates with decreased in vivo and in vitro insulin action in nondiabetic subjects: evidence that PC-1 may be an intrinsic factor in impaired insulin receptor signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900182-3

Increased adipose tissue PC-1 protein content, but not tumour necrosis factor-alpha gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900182-3

Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900182-3

Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900182-3

10.1016/S0026-0495(03)00182-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14506612%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference